Revenue Breakdown
Composition ()
No data
Revenue Streams
Bioharvest Sciences Inc (BHST) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Products, accounting for 94.6% of total sales, equivalent to $8.05M. Another important revenue stream is CDMO Services. Understanding this composition is critical for investors evaluating how BHST navigates market cycles within the Food Processing industry.
Profitability & Margins
Evaluating the bottom line, Bioharvest Sciences Inc maintains a gross margin of 61.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -10.15%, while the net margin is -27.72%. These profitability ratios, combined with a Return on Equity (ROE) of -200.22%, provide a clear picture of how effectively BHST converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BHST competes directly with industry leaders such as OMEX and BARK. With a market capitalization of $102.17M, it holds a significant position in the sector. When comparing efficiency, BHST's gross margin of 61.43% stands against OMEX's 100.00% and BARK's 62.53%. Such benchmarking helps identify whether Bioharvest Sciences Inc is trading at a premium or discount relative to its financial performance.
